A new study has revealed an increase in antipsychotic drugs use in long-term care homes across Canada despite no significant increase in behavioural symptoms of residents – something that may expose a potential area of concern for quality of care, researchers say.

The study, published in Health Services Insights, examined data from yearly Canadian Institute for Health Information (CIHI) reports to assess how COVID-19 impacted resident admission and discharge rates, resident health attributes, treatments, and quality of care.

The report data was collected two years pre-pandemic and in the first year of COVID-19, and was from more than 500,000 residents across Ontario, Manitoba, Alberta, and British Columbia.

Read more here:

CTV News
June 3, 2023